Mia's Feed
Medical News & Research

Monitoring Antibiotic Resistance Spread Through Wastewater Surveillance at Mass Events

Monitoring Antibiotic Resistance Spread Through Wastewater Surveillance at Mass Events

Share this article

Wastewater surveillance reveals how mass gatherings accelerate the spread of antibiotic resistance genes, highlighting environmental risks and the importance of genomic monitoring in public health.

2 min read

Mass gatherings, including major sporting events and festivals, attract large populations from diverse regions, creating opportunities for the spread of antimicrobial resistance (AMR). This threat compromises the effectiveness of antibiotics and presents significant public health challenges. To better understand how such events influence the dissemination of resistance genes, researchers have utilized wastewater surveillance to monitor changes in the presence of antimicrobial resistance genes (ARGs). The COVID-19 pandemic provided a unique baseline, as border closures temporarily reduced travel and large gatherings, allowing scientists to assess how the resumption of these events impacts local wastewater systems.

A recent study led by Changzhi Wang from King Abdullah University of Science and Technology analyzed wastewater samples collected from four treatment plants in Saudi Arabia between July 2020 and August 2022. These plants received sewage from areas hosting mass gatherings, alongside samples from a control site that did not receive such wastewater. Using metagenomic techniques, the study focused on ARGs conferring resistance to beta-lactam antibiotics, like metallo-beta-lactamase (MBL) and extended-spectrum beta-lactamase (ESBL). The results showed spikes in the abundance of these resistance genes following mass events in 2022, correlating with increased populations resistant to antibiotics such as meropenem and ceftazidime.

Additionally, the presence of resistance genes like blaPER was identified in pathogenic bacteria during peak gathering periods, suggesting that such events can introduce new resistance determinants into local environments. Notably, no resistant colonies were detected at the control site, which did not receive wastewater from large gatherings.

Researchers emphasized that traditional methods of monitoring might overlook subtle but critical changes in resistance patterns. Integrating genomics approaches with bioinformatic analysis offers a more comprehensive understanding of how mass gatherings influence AMR spread. Public health strategies could benefit from wastewater and water surveillance, especially in regions with inadequate wastewater treatment infrastructure, to anticipate and mitigate the risks posed by antimicrobial resistance.

This research underscores the importance of monitoring environmental reservoirs of resistance and highlights the potential of metagenomics as a tool in public health surveillance to combat the growing challenge of antimicrobial resistance, especially during large-scale events.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Fall Vaccination Guidance: Protect Yourself Against Flu and COVID-19

Stay protected this fall with important guidance on flu and COVID-19 vaccinations. Learn why vaccines are safe, effective, and essential for preventing severe illness and outbreaks during the upcoming season.

The Impact of Cannabis on Female Reproductive Health and IVF Outcomes

Emerging research indicates that cannabis use can disrupt female fertility, impair oocyte quality, and increase chromosomal abnormalities in IVF treatments. Learn how THC affects reproductive health and pregnancy outcomes.

Decline in Patient Outcomes at Hospitals Acquired by Private Equity Firms

Research reveals hospitals acquired by private equity firms face increased patient mortality and transfer rates due to staffing reductions, raising concerns about care quality.

Timing of Hormone Replacement Therapy Key to Alzheimer's Disease Risk

New research suggests that starting hormone replacement therapy within five years of menopause can reduce Alzheimer's disease risk, while delaying treatment may increase it, emphasizing the importance of timing.